Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Hye Rim Hwang 2 Articles
Genetic changes in plaque-purified varicella vaccine strain Suduvax during in vitro propagation in cell culture
Hye Rim Hwang , Se Hwan Kang , Chan Hee Lee
J. Microbiol. 2021;59(7):702-707.   Published online June 1, 2021
DOI: https://doi.org/10.1007/s12275-021-1062-3
  • 609 View
  • 3 Download
AbstractAbstract PDF
Infection by varicella-zoster virus (VZV) can be prevented by using live attenuated vaccines. VZV vaccine strains are known to evolve rapidly in vivo, however, their genetic and biological effects are not known. In this study, the plaque-purified vaccine strain Suduvax (PPS) was used to understand the genetic changes that occur during the process of propagation in in vitro cell culture. Full genome sequences of three different passages (p4, p30, and p60) of PPS were determined and compared for genetic changes. Mutations were found at 59 positions. The number of genetically polymorphic sites (GPS) and the average of minor allele frequency (MAF) at GPSs were not significantly altered after passaging in cell culture up to p60. The number of variant nucleotide positions (VNPs), wherein GPS was found in at least one passage of PPS, was 149. Overall, MAF changed by less than 5% at 52 VNPs, increased by more than 5% at 42 VNPs, and decreased by more than 5% at 55 VNPs in p60, compared with that seen in p4. More complicated patterns of changes in MAF were observed when genetic polymorphism at 149 VNPs was analyzed among the three passages. However, MAF decreased and mixed genotypes became unequivocally fixed to vaccine type in 23 vaccine-specific positions in higher passages of PPS. Plaque-purified Suduvax appeared to adapt to better replication during in vitro cell culture. Further studies with other vaccine strains and in vivo studies will help to understand the evolution of the VZV vaccine.
Increase in the genetic polymorphism of varicella-zoster virus after passaging in in vitro cell culture
Hye Rim Hwang , Seok Cheon Kim , Se Hwan Kang , Chan Hee Lee
J. Microbiol. 2019;57(11):1033-1039.   Published online October 28, 2019
DOI: https://doi.org/10.1007/s12275-019-9429-4
  • 961 View
  • 1 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Primary infections with the varicella-zoster virus (VZV) result in varicella, while latent reactivation leads to herpes zoster. Both varicella and zoster can be prevented by live attenuated vaccines. There have been reports suggesting that both clinical VZV strains and those in vaccine preparations are genetically polymorphic, containing mixtures of both wild-type and vaccine-type sequences at certain vaccine-specific sites. In this study, the genetic polymorphism of the VZV genome was examined by analyzing the frequencies of minor alleles at each nucleotide position. Next-generation sequencing of the clinical VZV strain YC02 passaged in an in vitro cell culture was used to identify genetically polymorphic sites (GPS), where the minor allele frequency (MAF) exceeded 5%. The number of GPS increased by 7.3-fold at high passages (p100) when compared to low passages (p17), although the average MAF remained similar. GPS were found in 6 open reading frames (ORFs) in p17, 35, and 54 ORFs in p60 and p100, respectively. GPS were found more frequently in the dispensable gene group than the essential gene group, but the average MAF was greater in the essential gene group. The most common two major/minor base pairs were A/g and T/c. GPS were found in all three passages at 16 positions, all located in the reiterated (R) region. The population diversity as measured by Shannon entropy increased in p60 and p100. However, the entropy remained unchanged in the R regions.

Citations

Citations to this article as recorded by  
  • Genomic comparison reveals single-nucleotide polymorphic sites and attenuation-associated site combinations specific to Chinese live attenuated varicella-zoster virus vaccines
    Yuchan Zhang, Xuhua Duan, Yuanyuan Cai, Mingren Wang, Ziqiang Wang, Minghui Song, Tianyi Qiu, Xuanyi Wang, Hong Shao
    Human Vaccines & Immunotherapeutics.2026;[Epub]     CrossRef
  • Biological relevance of in vitro cellular models to study varicella-zoster virus—host cell interactome: current limitations and future perspectives
    Jonas Govaerts, Charlotte Goethals, Elise Van Breedam, Catherine Sadzot-Delvaux, Peter Delputte, Benson Ogunjimi, Marielle Lebrun, Peter Ponsaerts, Stanley Perlman
    Microbiology and Molecular Biology Reviews.2025;[Epub]     CrossRef
  • Genetic changes in plaque-purified varicella vaccine strain Suduvax during in vitro propagation in cell culture
    Hye Rim Hwang, Se Hwan Kang, Chan Hee Lee
    Journal of Microbiology.2021; 59(7): 702.     CrossRef
  • Genetic diversity through social heterosis can increase virulence in RNA viral infections and cancer progression
    Saba Ebrahimi, Peter Nonacs
    Royal Society Open Science.2021;[Epub]     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP